По вашему запросу найдено документов: 28

Страница 1 из 3

ARSENIC TRIOXIDE BLOCKED PROLIFERATION AND CARDIOMYOCYTE DIFFERENTIATION OF HUMAN INDUCED PLURIPOTENT STEM CELLS: IMPLICATION IN CARDIAC DEVELOPMENTAL TOXICITY
BAO, Z., HAN, Z., ZHANG, B., YU, Y., XU, Z., MA, W., DING, F., ZHANG, L., YU, M., LIU, S., JIN, M., YAN, G., HUANG, Q., WANG, X., HUA, B., YANG, F., LI, Y., LIU, Y., LI, B., WANG, N., CAI, B., ZAGIDULLIN, N., CARVALHO, K. (2019)
ATOonhumancardiacdevelopmentbyusingavitrocardiacdifferentiationmodel ofhumaninducedpluripotentstemcells(hiPSCs).Herewefoundthatclinicallyachievableconcentrations(0.1, 0.5 and 1μM) of ATO resulted in a
ИНДУЦИРОВАННЫЕ ПЛЮРИПОТЕНТНЫЕ СТВОЛОВЫЕ КЛЕТКИ ДЛЯ РЕГЕНЕРАТИВНОЙ МЕДИЦИНЫ
INDUCED PLURIPOTENT STEM CELLS FOR REGENERATIVE MEDICINE
Латыпов, В.Д., Гильманов, Э.Р., Latypov, V.D., Gilmanov, E.R. (2024)
induced pluripotent stem cells (iPSCs)
Human-Induced Pluripotent Stem Cells-Derived Corneal Endothelial-Like Cells Promote Corneal Transparency in a Rabbit Model of Bullous Keratopathy
Sun, BQ, Bikkuzin, T, Li, XR, Shi, Y, Zhang, H (2021)
induced pluripotent stem cells (iPSCs) into CECs. After the identification of differentiated CECs
OPINIONS OF HEARING PARENTS ABOUT THE CAUSES OF HEARING IMPAIRMENT OF THEIR CHILDREN WITH BIALLELIC GJB2 MUTATIONS
Solovyev, A.V., Dzhemileva, L.U., Posukh, O.L., Barashkov, N.A., Bady-Khoo, M.S., Lobov, S.L., Popova, N.Y., Romanov, G.P., Sazonov, N.N., Bondar, A.A., Morozov, I.V., Tomsky, M.I., Fedorova, S.A., Khusnutdinova, E.K. (2017)
Abstract Hereditary hearing impairment (HI) caused by recessive GJB2 mutations is a frequent
Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis
Ruperto, N, Brunner, HI, Pacheco-Tena, C, Louw, I, Vega-Cornejo, G, Spindler, AJ, Kingsbury, DJ, Schmeling, H, Borzutzky, A, Cuttica, R, Inman, CJ, Malievskiy, V, Scott, C, Keltsev, V, Terreri, MT, Viola, DO, Xavier, RM, Fernandes, TAP, Velazquez, MDM, Henrickson, M, Clark, MB, Bensley, KA, Li, XM, Lo, KH, Leu, JH, Hsu, CH, Hsia, EC, Xu, ZH, Martini, A, Lovell, DJ, Group Authors:Pediat Rheumatology Collaborative (Pediat Rheumatology Collaborative), Paediat Rheumatology Int Trials Or (Paediat Rheumatology Int Trials Or) (2021)
Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Larionova, Irina, Iamshchikov, Pavel, Kazakova, Anna, Rakina, Militsa, Menyalo, Maxim, Enikeeva, Kadriia, Rafikova, Guzel, Sharifyanova, Yuliya, Pavlov, Valentin, Villert, Alisa, Kolomiets, Larisa, Kzhyshkowska, Julia (2025)
based on feature gene expression – CD14.Mn.S100A8.9hi, CD14.Mn.MHC2hi and CD16.Mn subsets
SPECTRUM AND FREQUENCY OF THE GJB2 GENE PATHOGENIC VARIANTS IN A LARGE COHORT OF PATIENTS WITH HEARING IMPAIRMENT LIVING IN A SUBARCTIC REGION OF RUSSIA (THE SAKHA REPUBLIC)
Barashkov, Nikolay A., Pshennikova, Vera G., Posukh, Olga L., Teryutin, Fedor M., Solovyev, Aisen V., Klarov, Leonid A., Romanov, Georgii P., Gotovtsev, Nyurgun N., Kozhevnikov, Andrey A., Kirillina, Elena V., Sidorova, Oksana G., Vasilyevа, Lena M., Fedotova, Elvira E., Morozov, Igor V., Bondar, Alexander A., Solovyevа, Natalya A., Kononova, Sardana K., Rafailov, Adyum M., Sazonov, Nikolay N., Alekseev, Anatoliy N., Tomsky, Mikhail I., Dzhemileva, Lilya U., Khusnutdinova, Elza K., Fedorova, Sardana A. (2016)
of hearing impairment (HI). More than 300 allelic variants have been identified in the GJB2 gene. Spectrum
ИСКУССТВЕННЫЙ ИНТЕЛЛЕКТ КАК ИНСТРУМЕНТ ПОДДЕРЖКИ В ПРИНЯТИИ РЕШЕНИЙ ПО ДИАГНОСТИКЕ ОНКОЛОГИЧЕСКИХ ЗАБОЛЕВАНИЙ
ARTIFICIAL INTELLIGENCE AS A TOOL FOR DECISION-MAKING SUPPORT IN THE DIAGNOSTICS OF ONCOLOGICAL DISEASES
Ш. Х. Ганцев, Sh. Kh. Gantsev, М. В. Франц, M. V. Frants (Медицинский вестник Башкортостана, №4, 2018)
LDR-БРАХИТЕРАПИЯ И HIFU-ТЕРАПИЯ В ЛЕЧЕНИИ ЛОКАЛИЗОВАННЫХ ФОРМ РАКА ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫ. БЛИЖАЙШИЕ И ОТДАЛЕННЫЕ ОСЛОЖНЕНИЯ. ОПЫТ ГБУЗ СО «СВЕРДЛОВСКАЯ ОБЛАСТНАЯ КЛИНИЧЕСКАЯ БОЛЬНИЦА № 1»
LDR-BRACHYTHERAPY AND HIFU THERAPY IN THE TREATMENT OF LOCALIZED FORMS OF PROSTATE CANCER. IMMEDIATE AND LONG-TERM COMPLICATIONS. EXPERIENCE OF REGIONAL CLINICAL HOSPITAL № 1
Р. Ю. Коваленко, R. Yu. Kovalenko, Д. В. Тевс, D. V. Tevs, О. К. Узбеков, O. K. Uzbekov, И. В. Баженов, I. V. Bazhenov, И. В. Борзунов, I. V. Borzunov, Д. А. Сорочкин, D. A. Sorochkin, В. С. Потапов, V. S. Potapov (Медицинский вестник Башкортостана, №3, 2017)
HiFu-терапия
Резолюция Совета экспертов Нейтрализующие моноклональные антитела при COVID-19 – место в терапии уязвимых категорий больных
Resolution Consensus Statement Neutralizing monoclonal antibodies for treatment of COVID-19 – a role in the treatment of vulnerable categories of patients
Чуланов, В.П., Шмаков, Р.Г., Лиознов, Д.А., Абдулганиева, Д.И., Валишин, Д.А., Грабовский, В.М., Иванова, М.Р., Катанахова, Л.Л., Кузнецов, П.Л., Мутовина, З.Ю., Поликарпова, О.В., Сагалова, О.И., Сметанина, С.В., Хаертынов, Х.С., Chulanov, V.P., Shmakov, R.G., Lioznov, D.A., Abdulganieva, D.I., Valishin, D.A., Grabovsky, V.M., Ivanova, M.R., Katanakhova, L.L., Kuznetsov, P.L., Mutovina, Z.Yu., Polikarpova, O.V., Sagalova, O.I., Smetanina, S.V., Khaertynov, Kh.S. (2023)

Страница 1 из 3

Google Scholar
OpenDoar

Фасеты

Научный руководитель
Авторы
Ключевые слова
Год